Farallon Capital Management’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40K | Hold |
28,000
| – | – | ﹤0.01% | 134 |
|
|
2025
Q1 | $44.8K | Hold |
28,000
| – | – | ﹤0.01% | 135 |
|
|
2024
Q4 | $101K | Hold |
28,000
| – | – | ﹤0.01% | 135 |
|
|
2024
Q3 | $160K | Hold |
28,000
| – | – | ﹤0.01% | 142 |
|
|
2024
Q2 | $129K | Hold |
28,000
| – | – | ﹤0.01% | 142 |
|
|
2024
Q1 | $229K | Buy |
+28,000
| New | +$229K | ﹤0.01% | 138 |
|